A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance

Optify

Status

Completed

Conditions

Polycystic Ovary Syndrome

Hormone Imbalance

Treatments

Dietary Supplement: Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT06158932

20366

Details and patient eligibility

About

This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. Questionnaires will be completed at Baseline, Week 4, Week 8 and Week 12. Participants will also provide a waist circumference measurement at Baseline and Week 12.

Enrollment

40 patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Women aged between 18 - 55
BMI less than 35
Self-reported symptoms of PCOS like irregular periods, excessive hair growth, weight gain, oily skin, or acne
Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
Self-reported concerns with hormonal skin issues
Has access to a tape measure for waist measurement
Generally healthy - don't live with any uncontrolled chronic disease

Exclusion criteria

Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
Anyone with known severe allergic reactions
Anyone who is pregnant or breastfeeding
Unwilling to follow the study protocol